Medscape

Bladder-cancer risk in Wegener's granulomatosis linked to cyclophosphamide dose

Uppsala, Sweden - The risk of bladder cancer rises steadily with increasing cumulative dose of cyclophosphamide in patients with Wegener's granulomatosis (WG), although some of this risk is ...
ascopubs.org

High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose ...

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. Fifty-six patients with non-Hodgkin's lymphoma (NHL, n = 26), Hodgkin's ...
ascopubs.org

Phase III Trial Comparing Two Dose Levels of Epirubicin Combined With Cyclophosphamide With Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer

Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease PURPOSE: To compare a full-dose epirubicin-cyclophosphamide (HEC) regimen with classical cyclophosphamide, ...
Healio

Novel regimen reduces chronic GVHD after allogeneic stem cell transplantation

Please provide your email address to receive an email when new articles are posted on . The addition of post-transplant cyclophosphamide to sirolimus and cyclosporine reduced chronic GVHD. Efforts are ...

Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL

Nexus Pharmaceuticals, LLC announces the launch of Cyclophosphamide Injection, available in ready to dilute 2.5 mL fill and 5 mL fill multiple-dose vials. As the first AP Rated Generic to Dr. Reddy's, ...